Shanghai set out plans on May 16 for the end of a painful COVID-19 lockdown that has lasted more than six weeks, heavily bruising China’s economy, and for the return of more normal life from June 1.
Cancer diagnosis a year before infection not linked to worse outcomes; air travel carries COVID risks
Airline passengers, Airlines, Airports, Cancer, Cancer diagnosis, Coronavirus Infections, COVID-19 Mortality, COVID-19 Studies, COVID-19 transmission, Hospitalized COVID-19 Patients, Journal of Travel Medicine, R&DPatients diagnosed with cancer more than a year before contracting COVID-19 and those not receiving active treatment may be no more vulnerable to worse COVID outcomes than those without cancer, according to a new study. Additionally, researchers warned that passengers are still at risk of coronavirus infection while traveling on airplanes and also in airports.
The head of the World Health Organization on April 26 urged countries to maintain surveillance of coronavirus infections, saying the world was “blind” to how the virus is spreading because of falling testing rates.
WHO analyzing two new Omicron COVID sub-variants
B.1.1.7 "Kent" strain (United Kingdom), B.1.1.7 Variant (UK), Coronavirus Disease 2019 (COVID-19), COVID-19 cases, COVID-19 Origins, COVID-19 recommendations, COVID-19 transmission, COVID-19 Variant B.1.1.7, Covid-19 Variants, Omicron (B.1.1.529) (South Africa), Omicron BA.2, R&DThe World Health Organization said on April 11 it is tracking a few dozen cases of two new sub-variants of the highly transmissible Omicron strain of the coronavirus to assess whether they are more infectious or dangerous.
The U.S. national public health agency said on April 4 the BA.2 sub-variant of Omicron was estimated to account for nearly three of every four coronavirus variants in the country.
Explainer: Omicron ‘stealth’ COVID variant BA.2 now dominant globally
Asia, China, Coronavirus Disease 2019 (COVID-19) Reinfections, COVID-19 transmission, COVID-19 Vaccinations, Europe, Germany, Omicron (B.1.1.529) (South Africa), Omicron BA.2, Public Health Crisis, R&D, Scientists, United Kingdom, United StatesA sub-variant of the highly transmissible Omicron version of coronavirus known as BA.2 is now dominant worldwide, prompting surges in many countries in Europe and Asia and raising concern over the potential for a new wave in the United States.
COVID-19 Update: Benefit of 4th Booster Could be Modest, New White House Coordinator
Appointments, Babies, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease 2019 (COVID-19), COVID-19 booster shots, COVID-19 shots, COVID-19 transmission, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Dr. Anthony Fauci (Director), Emergency Use Authorization (EUA), FDA, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), National Institute of Allergy and Infectious Diseases (NIAID), Newborns, Omicron BA.2, People on the Move, Pfizer, White HouseWhile Moderna and Pfizer-BioNTech have submitted Emergency Use Authorization (EUA) requests for their COVID-19 vaccines, the data so far suggest the benefits of a fourth shot may be modest.
The Pan American Health Organization (PAHO) on March 9 said COVID-19 cases fell by 26 percent across the Americas during the previous week while deaths from the virus dropped by nearly 19 percent, but cautioned that some effective measures to curb infections should be maintained.
The U.S. Centers for Disease Control and Prevention (CDC) on February 25 dramatically eased its COVID-19 guidelines for masks, including in schools, a move that means 72% of the population reside in communities where indoor face coverings are no longer recommended.
The Omicron BA.2 sub-variant of COVID-19 appears to be more infectious than the original BA.1 sub-variant, but does not cause more severe disease, the head of Africa’s top public health body said on February 24 citing data from South Africa.